Disse var i gennemsnit mere alvorlige end de infektioner, der var manifest hos 27% af alle patienter, der modtager en reduceret dosis på 0, 5 mg/ kg legemsvægt pr. cyklus.
These were on average more severe than the infections manifested in 27% of all patients receiving a reduced dose of 0.5 mg/ kg body weight per cycle.